Uncontrolled Blood Pressure: Why Millions Skip Meds?

A staggering 80% of US adults with hypertension have uncontrolled blood pressure, and a concerning majority aren’t even on medication – despite being close to treatment goals and, crucially, *having access to healthcare*. This isn’t simply a matter of missed diagnoses; it’s a systemic failure in blood pressure management, revealing deep-seated issues in treatment initiation, intensification, and adherence, and potentially exposing a significant portion of the population to avoidable cardiovascular and cognitive decline. New research, published February 2, 2026, underscores the urgency of addressing these gaps as the American Heart Association/American College of Cardiology (AHA/ACC) guidelines tighten in 2025.

The study, utilizing data from the National Health and Nutrition Examination Survey (NHANES) 2021-2023, paints a stark picture. The findings are particularly troubling given the recent lowering of blood pressure thresholds by the AHA/ACC. For decades, the 140/90 mmHg guideline served as a common benchmark. The shift to 130/80 mmHg, intended to reduce cardiovascular risk, has inadvertently exposed a larger population as needing treatment. However, simply *identifying* more patients isn’t enough; this data suggests the system is failing to effectively engage and manage them.

The research, and commentary from experts like Dr. Shakia Hardy of UNC Chapel Hill, points to a multi-faceted problem. It’s not solely a lack of awareness – most patients are aware of their hypertension. It’s not primarily a cost barrier – antihypertensive medications are generally affordable. Instead, the issue appears to be a combination of clinical inertia (hesitancy to initiate or intensify treatment), patient hesitancy rooted in familiarity with older guidelines, and a systemic failure to prioritize proactive blood pressure management within routine care. The fact that 80% of those with uncontrolled blood pressure *have* health insurance and a regular healthcare provider is particularly damning.

The Forward Look

This study isn’t just a report on the current state; it’s a warning. We can anticipate several key developments in the coming years:

• Increased Focus on Early Intervention: Clinicians will likely face growing pressure to initiate antihypertensive therapy earlier, even at blood pressure levels slightly above the 130/80 mmHg threshold, particularly in younger adults. Dr. Hardy’s emphasis on treating younger patients proactively is likely to gain traction.
• Shift Towards Combination Therapy: The data strongly suggests a need to move away from monotherapy as a first-line treatment. Expect increased adoption of combination pill strategies to achieve faster and more effective blood pressure control.
• Enhanced Patient Education & Risk Communication: Framing blood pressure control not just as “heart health” but as “brain protection” – emphasizing the link to dementia – could prove a powerful motivator for patients. Healthcare systems will need to invest in clear, accessible educational materials.
• Quality Metric Adjustments: Payers and regulatory bodies will likely incorporate more stringent blood pressure control metrics into quality reporting and reimbursement models, incentivizing providers to improve performance.
• Further Research on Younger Populations: A critical need exists for more clinical trials specifically focused on hypertension treatment in younger adults to provide evidence-based guidance for this understudied group.

Ultimately, addressing this crisis requires a fundamental shift in how hypertension is approached – from a reactive, episodic treatment of a “disease of aging” to a proactive, continuous management of a significant risk factor across the lifespan. The stakes are high, with both cardiovascular health and cognitive function hanging in the balance.

References

1. Hardy ST, Jaeger BC, Emanuel E, Muntner P. Blood pressure above goal among US adults with hypertension. JAMA. Published online February 2, 2026. doi:10.1001/jama.2025.25657

2. Writing Committee Members*, Jones DW, Ferdinand KC, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152(11):e114-e218. doi:10.1161/CIR.0000000000001356